NLRP3 Inhibitor (BioAge Labs)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNLRP3 Inhibitor (BioAge Labs)
Drug Alias NameOcular topical product
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitors
TargetsNACHT, LRR and PYD domains-containing protein 3
Therapy Area/IndicationsOcular inflammationHealthy AgingXerophthalmia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBioAge Labs Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioAge Labs Inc
Active IndicationsN/A
Inactive IndicationsOcular inflammationHealthy AgingXerophthalmia

Other Information

ATC CodeN/A
Related LinksN/A